Table 1.
Demographic and clinical characteristics of subjects in the 21 voxel-based morphometry data sets included in the meta-analysis
| Study | Number (female) | Age (years) | Duration (years) | BMI | BDI score | Onset age (years) | Medication (%) | Comorbidity | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AN | HC | AN | HC | AN | HC | ||||||
| Samples from adults | |||||||||||
| Amianto et al. (2013) | 17(17) | 14(14) | 20 | 24 | 1.08 | 16.0 | 21.0 | 13 | NA | Drug naive | No |
| Bar et al. (2015) | 26(23) | 26(23) | 22.9 | 24 | 1.86 | 16.9 | 21.7 | 20 | NA | Drug naive | No |
| Bjornsdotter et al. (2018) | 25(25) | 25(25) | 20.3 | 21.2 | 4.14 | 16.2 | 21.1 | 26.88 | NA | 52 | Yes |
| Boghi et al. (2010) | 21(21) | 27(27) | 29 | 30.8 | 11.3 | 15.5 | 21.9 | NA | NA | 100 (SSRI) | NA |
| Brooks et al. (2011) | 14(14) | 21(21) | 26 | 26 | 9.2 | 15.6 | 21.4 | NA | NA | NA | Yes |
| Cicerale et al. (2013) | 10(10) | 8(8) | 22 | 24 | 1.33 | 15.9 | 21.1 | NA | 20 | Drug naive | No |
| D’Agata et al. (2015) | 21(21) | 17(17) | 21 | 23 | <2 | 16.1 | 21.5 | NA | NA | Drug naive | No |
| Fonville et al. (2014) | 31(NA) | 31(NA) | 23 | 25 | 7 | 15.8 | 21.8 | NA | 16 | 39 | Yes |
| Friederich et al. (2011) | 12(12) | 14(14) | 24.3 | 25.6 | 6.3 | 15.9 | 21.1 | NA | NA | Drug naive | No |
| Joos et al. (2010) | 12(12) | 18(18) | 25 | 26.9 | 4.7 | 16.0 | 21.2 | 26.5 | NA | 8.3 | Yes |
| Kohmura et al. (2017) | 23(23) | 29(29) | 28.5 | 28.2 | 10.5 | 13.2 | 21.5 | 25.3 | 18 | NA | No |
| Phillipou et al. (2018) | 26(26) | 27(27) | 22.8 | 22.5 | 6.42 | 16.6 | 22.6 | NA | 16.04 | 100 | Yes |
| Suchan et al. (2010) | 15(15) | 15(15) | 26.8 | 29.5 | 5.5 | 16.0 | 22.0 | NA | NA | NA | NA |
| Van Opstal et al. (2015) | 10(10) | 11(11) | 22.1 | 20.8 | 3.54 | 15.6 | 20.3 | NA | NA | 25 | No |
| Samples from adolescents | |||||||||||
| Bomba et al. (2015) | 11(11) | 8(8) | 13.6 | 13.2 | 1.20 | 12.7 | 19.8 | NA | NA | Drug naive | No |
| Castro Fornieles et al. (2009) | 12(11) | 9(8) | 14.5 | 14.6 | 0.69 | 14.8 | NA | NA | NA | 25 | Yes |
| Frank et al. (2013) | 19(19) | 22(22) | 15.4 | 14.8 | NA | 16.2 | 21.3 | NA | NA | 58 | Yes |
| Fujisawa et al. (2015) | 20(20) | 14(14) | 14.1 | 14.9 | 1.96 | 14.3 | NA | NA | NA | Drug naive | No |
| Gaudio et al. (2011) | 16(16) | 16(16) | 15.2 | 15.1 | 0.44 | 14.2 | 20.2 | NA | 14.7 | 100 | No |
| Martin Monzon et al. (2017) | 26(26) | 20(20) | 16.5 | 17.2 | <3 | 16.6 | 22.6 | NA | NA | NA | No |
| Olivo et al. (2018) | 22(22) | 38(38) | 14.7 | 14.8 | 0.66 | 19.3 | 20.7 | NA | NA | Drug naive | No |
BMI body mass index, AN anorexia nervosa, HC health control, BDI Beck Depression Inventory, R restrictive subtype of anorexia nervosa, NA not available